BioNTech SE (BNTX) Short term Debt (2018 - 2025)
Historic Short term Debt for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $698.4 million.
- BioNTech SE's Short term Debt rose 16321.71% to $698.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $698.4 million, marking a year-over-year increase of 16321.71%. This contributed to the annual value of $1.5 billion for FY2024, which is 24526.66% up from last year.
- According to the latest figures from Q3 2025, BioNTech SE's Short term Debt is $698.4 million, which was up 16321.71% from $164.1 million recorded in Q2 2025.
- In the past 5 years, BioNTech SE's Short term Debt ranged from a high of $11.1 billion in Q2 2022 and a low of $157.2 million during Q2 2024
- Over the past 5 years, BioNTech SE's median Short term Debt value was $466.4 million (recorded in 2025), while the average stood at $1.2 billion.
- Per our database at Business Quant, BioNTech SE's Short term Debt skyrocketed by 144137.37% in 2021 and then plummeted by 9830.46% in 2023.
- Over the past 5 years, BioNTech SE's Short term Debt (Quarter) stood at $1.4 billion in 2021, then tumbled by 41.18% to $801.0 million in 2022, then crashed by 44.23% to $446.7 million in 2023, then skyrocketed by 245.27% to $1.5 billion in 2024, then crashed by 54.72% to $698.4 million in 2025.
- Its Short term Debt stands at $698.4 million for Q3 2025, versus $164.1 million for Q2 2025 and $466.4 million for Q1 2025.